Atlas Trials

Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

Clinical trial NCT02645032 · COMPLETED

Trial details

NCT number
NCT02645032
Sponsor
International Vaccine Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Typhoid
Start date
2016-05-19
Primary completion
2017-02-09
Enrollment
144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.